Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1958 May 3;1(5078):1034–1037. doi: 10.1136/bmj.1.5078.1034

Alopecia following Treatment with Dextran Sulphate and Other Anticoagulant Drugs

G R Tudhope, H Cohen, R W Meikle
PMCID: PMC2028642  PMID: 13536411

Full text

PDF
1034

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., FLYGER H. H., GORMSEN J. The anticoagulant activity and toxicity of dextran sulphate and a xylan polysulphuric acid. Scand J Clin Lab Invest. 1955;7(3):204–211. doi: 10.3109/00365515509134511. [DOI] [PubMed] [Google Scholar]
  2. Allen J. G., Jacobson L. O. Hyperheparinemia: Cause of the Hemorrhagic Syndrome Associated With Total Body Exposure to Ionizing Radiation. Science. 1947 Apr 11;105(2728):388–389. doi: 10.1126/science.105.2728.388. [DOI] [PubMed] [Google Scholar]
  3. COHEN H., TUDHOPE G. R. Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol. Br Med J. 1956 Nov 3;2(5000):1023–1027. doi: 10.1136/bmj.2.5000.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DE TAKATS G. Anticoagulant therapy. Surgery. 1953 Dec;34(6):985–1004. [PubMed] [Google Scholar]
  5. DUFF I. F., LINMAN J. W., BIRCH R. The administration of heparin. Surg Gynecol Obstet. 1951 Sep;93(3):343–362. [PubMed] [Google Scholar]
  6. ENGELBERG H., KUHN R., STEINMAN M. A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis. Circulation. 1956 Apr;13(4):489–498. doi: 10.1161/01.cir.13.4.489. [DOI] [PubMed] [Google Scholar]
  7. FISCHER R., BIRCHER J., REICH T. Der Haarausfall nach antikoagulierender Therapie. Schweiz Med Wochenschr. 1953 May 30;83(22):509–511. [PubMed] [Google Scholar]
  8. HIRSCHBOECK J. S., MADISON F. W., PISCIOTTA A. V. Alopecia and other toxic effects of heparin and synthetic heparinoids. Am J Med Sci. 1954 Mar;227(3):279–282. [PubMed] [Google Scholar]
  9. JEAVONS S. M., RICKETTS C. R., WALTON K. W. Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate. Br Med J. 1956 Nov 3;2(5000):1016–1023. doi: 10.1136/bmj.2.5000.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PLANCHEREL P. Klinische und gerinnungsphysiologische Untersuchungen mit einem neuen Heparindepotpräparat. Z Klin Med. 1953;150(3):213–259. [PubMed] [Google Scholar]
  11. RICKETTS C. R. Dextran sulphate--a synthetic analogue of heparin. Biochem J. 1952 Apr;51(1):129–133. doi: 10.1042/bj0510129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RICKETTS C. R., WALTON K. W., VAN LEUVEN B. D., BIRBECK A., BROWN A., KENNEDY A. C., BURT C. C. Therapeutic trial of the synthetic heparin analogue dextran sulphate. Lancet. 1953 Nov 14;265(6794):1004–1010. doi: 10.1016/s0140-6736(53)91306-3. [DOI] [PubMed] [Google Scholar]
  13. VAN DYKE D. C., HUFF R. L. Epilation in the non-irradiated member of parabiotically united rats. Proc Soc Exp Biol Med. 1949 Oct;72(1):266–269. doi: 10.3181/00379727-72-17402. [DOI] [PubMed] [Google Scholar]
  14. WALTON K. W. The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties. Br J Pharmacol Chemother. 1952 Sep;7(3):370–391. doi: 10.1111/j.1476-5381.1952.tb00705.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WRIGHT I. S. An evaluation of anticoagulant therapy. Am J Med. 1953 Jun;14(6):720–730. doi: 10.1016/0002-9343(53)90391-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES